amfepramone oor Spaans
amfepramone
en
A stimulant drug used as an appetite suppressant.
Vertalings in die woordeboek Engels - Spaans
anfepramona
Prescription stimulants may include preparations containing amfepramone, fenetylline, methylphenidate, pemoline, phenmetrazine and phentermine.
Entre los estimulantes de venta bajo receta médica pueden incluirse los preparados que contienen anfepramona, fenetilina, metilfenidato, pemolina, fenmetracina y fentermina.
amfepramona
Geskatte vertalings
Vertoon algoritmies gegenereerde vertalings
voorbeelde
Advanced filtering
Voorbeelde moet herlaai word.
Prescription stimulants may include preparations containing amfepramone, fenetylline, methylphenidate, pemoline, phenmetrazine and phentermine.
¿ Cómo has llegado?UN-2 UN-2
1 By application lodged at the Registry of the Court of Justice on 27 December 2000, the Commission of the European Communities brought an appeal pursuant to Article 225 EC and the second paragraph of Article 50 of the EC Statute of the Court of Justice against the order made by the President of the Court of First Instance on 31 October 2000 in Case T-76/00 R Bruno Farmaceutici and Others v Commission [2000] ECR I-3557 (the order under appeal), by which the President of the Court of First Instance suspended operation of Commission Decision C(2000) 453 of 9 March 2000 concerning the withdrawal of marketing authorisations of medicinal products for human use which contain the following substance: amfepramone (the contested decision).
Yo haré el informeEurLex-2 EurLex-2
44 As regards the benefit/risk balance, the CPMP considered that [o]n the basis of the available evidence on [amfepramone's] efficacy, it is no longer possible to consider that amfepramone has therapeutic efficacy in the treatment of obesity or (as a consequence) that its benefit/risk balance is positive.'
¿ Concuerda que darnos la mano sería incongruente?Vengo por la carta de mi socio...... que Ud. le dijo al DrEurLex-2 EurLex-2
12 By letter of 31 August 1998, likewise addressed to the chairman of the CPMP, the Austrian Ministry of Labour, Health and Social Affairs pointed out that, in addition to phentermine and amfepramone, clobenzorex, fenbutrazate, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine and propylhexedrine belonged to the same group of amphetamine-related anorectics.
Déjalo ir te digo.- ¡ De acuerdo!EurLex-2 EurLex-2
These decisions cover, among others, the substances Amfepramone and Phentermine, mentioned by the Honourable Member.
Tengo pases para ustedesEurLex-2 EurLex-2
110 The findings relating to the absence of proof in the CPMP’s Note for Guidance and the national guidelines of the alleged change in the abovementioned scientific criterion (see paragraph 101 above) could be made by the Commission only on the basis of a complex examination of successive draft scientific reports prepared in the course of the examination procedure which led to the final opinion on amfepramone, and the guidelines mentioned in that final opinion (see paragraph 103 above).
Asunto C-#/#: Petición de decisión prejudicial planteada por el Sofiyski gradski sad (Bulgaria) el # de mayo de #- Canon Kabushiki Kaisha/IPN Bulgaria OODEurLex-2 EurLex-2
209 In this case, an examination of, in particular, the successive preparatory reports drawn up in the course of the administrative procedure relating to amfepramone confirms that the change in the CPMP's position as regards the evaluation of the efficacy of the substances in question followed the entry into force, in June 1998, of the Note for Guidance adopted by the CPMP in November 1997.
¿ Puedo seguir?EurLex-2 EurLex-2
1. Operation of the Commission's decision of 9 March 2000 concerning the withdrawal of marketing authorisations for medicinal products for human use which contain amfepramone (C(2000) 453) is suspended in relation to the applicant.
¿ Se considera unbuen marido?EurLex-2 EurLex-2
With regard to the fears expressed by the Belgian authorities, the CPMP, notwithstanding its conclusion that there was no clinical or epidemiological evidence showing an increased risk of cardiac valve disorders where amfepramone was used in single-agent therapy, recommended the withdrawal of marketing authorisations for medicinal products containing amfepramone.
¿ Y tu libro?Lo acabaré luegoEurLex-2 EurLex-2
66 It is clear that, in its assessments regarding the establishment of a prima facie case and the balance of interests, the order under appeal makes no mention of the considerations in the statement of reasons for the contested decision relating to the change in the scientific criteria for evaluating medicinal products for the treatment of obesity and to the lack of therapeutic efficacy of medicinal products containing amfepramone.
empresas de Actebis objetivo: venta al por mayor de productos de tecnología de la informaciónEurLex-2 EurLex-2
(Appeals — Second paragraph of Article 288 EC — Non-contractual liability of the Union — Conditions — Sufficiently serious breach of a rule of law conferring rights on individuals — Decision withdrawing marketing authorisations for medicinal products for human use containing amfepramone)
Me porté bien con Uds., Uds.Pórtense bien conmigoEurLex-2 EurLex-2
12 On 31 August 1999 the CPMP gave its opinion on medicinal products containing amfepramone.
Arreglas todoEurLex-2 EurLex-2
36 In their report of 17 August 1999 on amfepramone, the rapporteur and co-rapporteur in the appeal procedure, Professors Garattini and de Andres-Trelles, recommended that medicinal products containing amfepramone be withdrawn from the market.
No hay límitesEurLex-2 EurLex-2
38 The sixth plea alleges material errors in relation to the finding, made in point 45 of the order under appeal, that, while there is uncertainty as regards the risks associated with medicinal products containing amfepramone, such health risks are slight.
Escucha a tu madre, ShaneEurLex-2 EurLex-2
Moreover, the contested decision is founded on the alleged lack of efficacy of medicinal products containing amfepramone and not their lack of safety.
RevelaciónEurLex-2 EurLex-2
The President of the Court of First Instance did not take Annex II to the decision into consideration in that he failed to note that the CPMP examined additional scientific data subsequent to 1996 and omitted the fact that, according to the CPMP, the medicinal products containing amfepramone did not have the required efficacy.
Las Comunidades tendrán los recursos propios asignados, de conformidad con las normas fijadas en los siguientes artículos, para asegurar, de conformidad con el artículo # del Tratado constitutivo de la Comunidad Europea (denominado en adelanteEurLex-2 EurLex-2
24 Fourthly, the applicant argues that the contested decision has been adopted in contravention of Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products (OJ 1975 L 147, p. 1) in that the decision states that the benefit/risk balance for amfepramone is not favourable in the light of the new assessment criteria applied by the CPMP.
¿ Qué, no me crees?EurLex-2 EurLex-2
The report's authors concluded that, due to its potentials for tolerance and physiological dependence, amfepramone can only be used for less than three months, that [sic] contradicts current guidelines recommending long-term [obesity] treatment.
Flota en el aire, sin propósitoEurLex-2 EurLex-2
Amfepramone, fenetylline, methylphenidate, pemoline, phenmetrazine, phentermine.
La gente venía a preguntarme cosas...... a admirar mis plantas y a admirarme a míUN-2 UN-2
33 On 12 April 1999, Professor Winkler sent to the members of the CPMP a discussion paper which drew attention to the negative evaluation of the benefit/risk balance of the substances under consideration, which had been made in the assessment reports on amfepramone (referred to above), on phentermine (see below, paragraph 47 et seq.), and also on clobenzorex, fenproporex and norpseudoephedrine (see below, paragraph 61 et seq.), and summarised the oral observations made by the holders of the marketing authorisations concerned.
No, no sé cómo jugarEurLex-2 EurLex-2
Trenker points out that the contested decision was not adopted for a reason relating to risk to patients' health, but solely because amfepramone allegedly lacks therapeutic efficacy.
Cuando se sepa, todos los adictos vendrán a merodear por la casaEurLex-2 EurLex-2
With regard to the fears expressed by the Belgian authorities, the CPMP, notwithstanding its conclusion that there was no clinical or epidemiological evidence showing an increased risk of cardiac valve disorders where amfepramone was used in single-agent therapy, recommended the withdrawal of marketing authorisations for medicinal products containing amfepramone.
Sea como fuere, es una historia deplorableEurLex-2 EurLex-2
2. The order of the President of the Court of First Instance of the European Communities of 28 June 2000 in Case T-74/00 R Artegodan v Commission [2000] ECR II-2583 is cancelled and, as a consequence, operation of Commission Decision C(2000) 453 of 9 March 2000 concerning the withdrawal of marketing authorisations for medicinal products for human use which contain amfepramone ceases to be suspended.
Motivos invocados: Aplicación incorrecta del artículo #, apartado #, letra b), del Reglamento no #/#, así como falta de motivación o motivación insuficiente en relación con la solicitud de aplicación del artículo #, letra a), de dicho ReglamentoEurLex-2 EurLex-2
It is also pointed out that the risk of drug abuse and drug dependence precludes that amfepramone should be used for long-term treatment.
¿ Y sabe por qué lo fue?EurLex-2 EurLex-2
201 sinne gevind in 7 ms. Hulle kom uit baie bronne en word nie nagegaan nie.